Get the Daily Brief
Latest Biotech News
Technological Innovations in Organ Transplantation and Regenerative Medicine
Advances in organ transplantation leverage single-cell techniques, artificial intelligence, and novel therapeutics to enhance graft survival and transplant outcomes. Single-cell sequencing...
Synthetic Biology and Protein Engineering Drive Therapeutic Innovation
Synthetic biology breakthroughs continue to elevate therapeutic potential through advanced protein and RNA engineering. EPFL’s BindCraft platform democratizes protein binder design targeting...
Diet, Metabolism, and Gut-Brain Axis in Chronic and Neurological Diseases
Emerging studies have deepened understanding of dietary impacts on chronic and neurological conditions via metabolic and immunological pathways. Research from the Buck Institute reveals migration...
Biotech Fundraising and Industry Ecosystem Developments
The biotechnology sector continues robust capital inflows and ecosystem expansion. Patient Square Capital secured $3.1 billion in interim closing for its healthcare investment fund...
FDA Approves Subcutaneous Leqembi to Fight Alzheimer’s
The FDA has approved a new subcutaneous formulation of Eisai and Biogen’s Alzheimer’s drug Leqembi, marking an incremental strategic advancement to compete with Eli Lilly’s Kisunla. This approval...
Gut-Brain Immune Crosstalk Shapes Alzheimer’s Progression in Mice
Research at the Buck Institute for Research on Aging reveals that in a mouse model of Alzheimer’s disease (5XFAD), gut immune cells migrate into the brain, likely driven by chemokine CXCL12 and...
Novo Nordisk and Replicate Bioscience Collaborate on RNA Therapeutics
Novo Nordisk has engaged in a multiyear collaboration with Replicate Bioscience, investing up to $550 million to leverage Replicate’s self-replicating RNA (srRNA) platform for therapeutic...
AI and Machine Learning Drive Advances in Cancer and Medical Imaging
Cutting-edge AI applications continue to reshape medical diagnostics and therapeutic development. Johns Hopkins researchers introduced the MIGHT algorithm, optimizing early cancer detection tests...
Plexium Raises Funds Amid Pipeline Restructuring and Partnership Changes
Protein degrader startup Plexium secured an additional $60 million in funding to support ongoing development following strategic pipeline realignments and the loss of its Amgen collaboration. The...
CDC Leadership Turmoil Amidst COVID-19 Vaccine Policy Changes
Susan Monarez’s tenure as CDC director ended abruptly after less than a month due to reported disagreements with HHS Secretary Robert F. Kennedy Jr. over vaccine policies, coinciding with FDA’s...
Groundbreaking Pig-to-Human Lung Transplant: A Xenotransplantation Milestone
Chinese scientists successfully transplanted a genetically modified pig lung into a brain-dead human recipient, maintaining organ viability for nine days without immediate rejection. This...
Advancements in Immunotherapy Targeting Renal Cell Carcinoma
UCLA researchers report promising preclinical results for Allo CAR70-NKT, an off-the-shelf allogeneic cell therapy engineered to deliver a multipronged attack against metastatic renal cell...
Novel Molecular Mechanisms and Therapeutic Targets in Cancer Biology
Emerging research elucidates key molecular pathways driving cancer progression and resistance. Studies reveal CX26 stabilizes oncogenic c-Myc in pancreatic cancer, enhancing tumor aggressiveness....
Advances in AI-Driven Biomedical Education and Tools
Generative AI is increasingly integrated into biomedical engineering education and drug discovery platforms, enhancing critical thinking and accelerating therapeutic development. Innovative...
FDA narrows COVID booster approvals amid CDC leadership crisis
The U.S. Food and Drug Administration has approved updated COVID-19 booster vaccines targeted at a prevalent subvariant but limited eligibility to older adults and those with underlying...
AI accelerates cancer diagnostics and drug discovery platforms
Artificial intelligence (AI) continues to transform biotechnology with innovations in diagnostics and therapeutic discovery. The expansion of multiomics biomarker detection platforms, such as...
Off-the-shelf immunotherapies show promise in solid tumor models
Innovative off-the-shelf immunotherapies are advancing towards clinical application in cancer treatment. UCLA researchers have engineered AlloCAR70-NKT cells, allogeneic immune effectors designed...
Gut-brain axis immune dynamics and Alzheimer’s disease insights
Emerging research elucidates the intricate immunological crosstalk between the gut and brain in Alzheimer’s disease (AD). Studies using the 5XFAD amyloid-β mouse model reveal altered immune cell...
Novo Nordisk's RNA partnerships expand cardiometabolic therapeutics pipeline
Novo Nordisk has embarked on significant collaborations aimed at enhancing its pipeline for cardiometabolic disorders. The largest involves a multi-year research collaboration with Replicate...
Regulatory and legal developments in oncology diagnostics
Legal and regulatory landscapes continue to shape oncology diagnostic markets. A recent court ruling invalidated two patents asserted by Natera over NeoGenomics’ Radar ST minimal residual disease...